We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Archrock
AROC
$6.27B
| $8K | ﹤0.01% |
+956
| New | +$6.98K |
|
1302
Brink's
BCO
$4.88B
| $8K | ﹤0.01% |
+105
| New | +$6.11K |
|
1303
Bread Financial
BFH
$4.37B
| $8K | ﹤0.01% |
+138
| New | +$6.94K |
|
1304
Black Hills Corp
BKH
$5.42B
| $8K | ﹤0.01% |
+127
| New | +$7.6K |
|
1305
CACI
CACI
$11B
| $8K | ﹤0.01% |
+33
| New | +$7.6K |
|
1306
Commerce Bancshares
CBSH
$8.53B
| $8K | ﹤0.01% |
+163
| New | +$7.9K |
|
|
CCRN
1307
DELISTED
Cross Country Healthcare
CCRN
| $8K | ﹤0.01% |
+898
| New | +$7.3K |
|
1308
Check Point Software Technologies
CHKP
$13B
| $8K | ﹤0.01% |
+59
| New | +$7.21K |
|
1309
Core Laboratories
CLB
$488M
| $8K | ﹤0.01% |
+301
| New | +$6.15K |
|
1310
Darling Ingredients
DAR
$9.64B
| $8K | ﹤0.01% |
+137
| New | +$6.55K |
|
1311
Donaldson
DCI
$10.9B
| $8K | ﹤0.01% |
+144
| New | +$7.6K |
|
1312
Enphase Energy
ENPH
$4.96B
| $8K | ﹤0.01% |
+47
| New | +$5.96K |
|
1313
Essent Group
ESNT
$6.08B
| $8K | ﹤0.01% |
+183
| New | +$7.91K |
|
1314
Evercore
EVR
$12.4B
| $8K | ﹤0.01% |
+74
| New | +$6.59K |
|
1315
Eagle Materials
EXP
$6.29B
| $8K | ﹤0.01% |
+82
| New | +$7.63K |
|
1316
Factset
FDS
$9.36B
| $8K | ﹤0.01% |
+23
| New | +$7.6K |
|
1317
First Horizon
FHN
$12.2B
| $8K | ﹤0.01% |
+634
| New | +$7.43K |
|
1318
Graco
GGG
$12.9B
| $8K | ﹤0.01% |
+115
| New | +$7.69K |
|
1319
InterContinental Hotels
IHG
$23.9B
| $8K | ﹤0.01% |
+121
| New | +$7.12K |
|
1320
Kelly Services Class A
KELYA
$514M
| $8K | ﹤0.01% |
+374
| New | +$7.5K |
|
1321
Knight Transportation
KNX
$11.3B
| $8K | ﹤0.01% |
+201
| New | +$8.19K |
|
1322
Landstar System
LSTR
$5.93B
| $8K | ﹤0.01% |
+58
| New | +$7.61K |
|
1323
New Jersey Resources
NJR
$5.84B
| $8K | ﹤0.01% |
+223
| New | +$7.26K |
|
1324
Oceaneering
OII
$4.86B
| $8K | ﹤0.01% |
+1,065
| New | +$6.22K |
|
1325
Oil States International
OIS
$489M
| $8K | ﹤0.01% |
+1,662
| New | +$6.43K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.